Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04649060 |
| Title | Study of Melphalan Flufenamide (Melflufen) in Combination With Daratumumab in Relapsed Refractory Multiple Myeloma (LIGHTHOUSE) |
| Acronym | LIGHTHOUSE |
| Recruitment | Terminated |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Oncopeptides AB |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | POL | NOR | GRC | ESP | DEU | CZE | BGR |